Kinetics of Changes in Lymphocyte Sub-Populations in Mouse Lungs After Intrapulmonary Infection with M. bovis (Bacillus Calmette-Guerin) and Identity of Cells Responsible for IFNgamma Responses
Public Domain
-
2002/06/01
-
Details
-
Personal Author:
-
Description:Gamma interferon (IFN) plays a key role in host defense against pulmonary mycobacterial infections. A variety of lymphocyte subsets may participate in producing pulmonary IFN responses, but their relative contributions after mycobacterial infection have not been clearly elucidated. To address this question, C57Bl/6 female mice were infected by intrapulmonary instillation of 2·5 104 BCG (Mycobacterium bovis Bacillus Calmette-Guerin). Lymphocyte populations in lung interstitium were examined at different time points after the infection. BCG load in lungs peaked between 4 and 6 weeks post-infection and declined to very low levels by the 12th week of infection. Recovery of lung interstitial lymphocytes doubled by 4-6 weeks after infection and declined thereafter. Flow cytometric analysis of the lung-derived lymphocytes revealed that about 5% of the these cells made IFN in control mice, and this baseline IFN production involved T (CD3+NK1.1), NK (CD3NK1.1+) and NKT (CD3+NK1.1+) cells. As the BCG lung infection peaked, the total number of CD3+ T cells in the lungs increased threefold at 5-6 weeks post-infection. There was a marked increase (sixfold) in the number of T cells secreting IFN 5-6 weeks post-infection. Some increase was also noted in the NKT cells making IFN, but the numbers of NK cells making IFN in BCG-infected lungs remained unaltered. Our results suggest that whereas NK and NKT cells contribute to baseline IFN secretion in control lungs, expansion in the IFN-producing T-cell population was essentially responsible for the augmented response seen in lungs of BCG-infected mice. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0954-7894
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:405-410
-
Volume:128
-
Issue:3
-
NIOSHTIC Number:nn:20022967
-
Citation:Clin Exp Allergy 2002 Jun; 128(3):405-410
-
Contact Point Address:Dr; Daniel M. Lewis, Analytical Services Branch, HELD, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, USA
-
Email:dml1@cdc.gov
-
Federal Fiscal Year:2002
-
NORA Priority Area:
-
Peer Reviewed:True
-
Source Full Name:Clinical and Experimental Allergy
-
Collection(s):
-
Main Document Checksum:urn:sha-512:d6f02ab019929d5c7c0c0e3af3a4f5f569057ab174d519d72eae30293deee4b0bee54046d4cd45752cb496cf408b7a52e7c3384c6a7e565d8bc92e94348ea8c9
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like